A randomized, placebo-controlled, double-blind Phase 3 trial comparing, relative to placebo, the effect of Kinisoquin¿ on thromboembolic events in patients with metastatic or locally advanced pancreatic cancer (CATIQ P3)

Full Title

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Kinisoquin on Thromboembolic Events in Patients with Metastatic or Locally Advanced Pancreatic Cancer (CATIQ P3) (WCG IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Jeffrey Zwicker’s office at 646-608-3723.